
Sign up to save your podcasts
Or


U.S. stock futures are mixed after a sharp software-driven selloff, as renewed concern over AI disruption weighs on sentiment. Investors are watching big tech earnings after the close and parsing whether the AI trade is recalibrating rather than breaking. Crypto weakness and cautious forward guidance are adding to the defensive tone.
Software stocks slid as fears grew that generative AI could displace enterprise tools, despite pushback from Nvidia leadership. The move reflects valuation sensitivity more than a single catalyst, with investors reassessing near-term monetization timelines across AI-linked names.
Earnings are driving dispersion. Advanced Micro Devices (AMD) topped Q4 estimates but guided conservatively, highlighting heavy AI investment costs and limited China visibility. In contrast, Eli Lilly (LLY) surged after projecting up to 27% sales growth on obesity drugs, while Uber (UBER) and Chipotle (CMG) flagged softer near-term trends.
Trending tickers: AMD under pressure on guidance, LLY jumps on blockbuster demand, CMG slides as comps stall.
Takeaways:
AI enthusiasm is colliding with valuation discipline.
Earnings guidance matters more than beats.
Drugmakers are outperforming tech on growth visibility.
Market leadership is broadening beyond mega-cap software.
Volatility likely persists through peak earnings.
Yahoo Finance's flagship show, Morning Brief, is your go-to source for smarter investing and market moves.
Thoughts? Questions? Fan mail? Email us at [email protected].
Learn more about your ad choices. Visit megaphone.fm/adchoices
By Yahoo Finance4.8
55 ratings
U.S. stock futures are mixed after a sharp software-driven selloff, as renewed concern over AI disruption weighs on sentiment. Investors are watching big tech earnings after the close and parsing whether the AI trade is recalibrating rather than breaking. Crypto weakness and cautious forward guidance are adding to the defensive tone.
Software stocks slid as fears grew that generative AI could displace enterprise tools, despite pushback from Nvidia leadership. The move reflects valuation sensitivity more than a single catalyst, with investors reassessing near-term monetization timelines across AI-linked names.
Earnings are driving dispersion. Advanced Micro Devices (AMD) topped Q4 estimates but guided conservatively, highlighting heavy AI investment costs and limited China visibility. In contrast, Eli Lilly (LLY) surged after projecting up to 27% sales growth on obesity drugs, while Uber (UBER) and Chipotle (CMG) flagged softer near-term trends.
Trending tickers: AMD under pressure on guidance, LLY jumps on blockbuster demand, CMG slides as comps stall.
Takeaways:
AI enthusiasm is colliding with valuation discipline.
Earnings guidance matters more than beats.
Drugmakers are outperforming tech on growth visibility.
Market leadership is broadening beyond mega-cap software.
Volatility likely persists through peak earnings.
Yahoo Finance's flagship show, Morning Brief, is your go-to source for smarter investing and market moves.
Thoughts? Questions? Fan mail? Email us at [email protected].
Learn more about your ad choices. Visit megaphone.fm/adchoices

3,229 Listeners

532 Listeners

409 Listeners

2,192 Listeners

435 Listeners

302 Listeners

685 Listeners

1,043 Listeners

353 Listeners

1,313 Listeners

214 Listeners

86 Listeners

146 Listeners

52 Listeners

27 Listeners

4 Listeners

8 Listeners

15 Listeners

0 Listeners

0 Listeners

0 Listeners

0 Listeners

3 Listeners

22 Listeners

5 Listeners

3 Listeners

4 Listeners

0 Listeners

0 Listeners

0 Listeners

9 Listeners

24 Listeners